Jr. Passweg et al., INFLUENCE OF PROTECTIVE ISOLATION ON OUTCOME OF ALLOGENEIC BONE-MARROW TRANSPLANTATION FOR LEUKEMIA, Bone marrow transplantation, 21(12), 1998, pp. 1231-1238
Various isolation strategies are used to prevent infections during bon
e marrow transplantation; data on their efficacy are lacking. We studi
ed whether use of high efficiency particulate air filtration (HEPA) an
d/or laminar airflow (LAF) units affect transplant-related mortality (
TRM) or survival in the first year after allogeneic transplantation. 5
065 patients with leukemia receiving bone marrow transplants from an H
LA identical sibling (n = 3982) or alternative related or unrelated do
nors (n = 1083) between 1988 and 1992 were reported to the Internation
al Bone Marrow Transplant Registry by 222 teams. Two types of isolatio
n were considered: (1) conventional protective isolation with single p
atient room and any combination of hand-washing, gloves, mask and gown
; and (2) HEPA and/or LAF. Cox proportional hazards regression models
were used to determine the relative risks (RRs) of transplant-related
mortality (TRM) and of deaths from any cause in patients treated in HE
PA/LAF units compared to patients treated in conventional isolation. H
LA-identical sibling and alternative donor transplants were analyzed s
eparately. Risks of TRM and overall mortality in the first 100 days po
st-transplant were significantly lower among patients treated in HEPA/
LAF units than in those treated conventionally. RRs of TRM were 0.76 (
P = 0.009) for recipients of HLA-identical sibling transplants and 0.6
5 (P = 0.003) for recipients of alternative donor transplants. Corresp
ondingly RRs of overall mortality were 0.80 (P = 0.02) and 0.65 (P = 0
.0006). Decreased risks of TRM and of death in the first 100 days post
-transplant resulted in significantly higher 1-year survival rates in
patients treated in HEPA/LAF rather than in conventional isolation uni
ts. Use of HEPA and/or LAF to prevent infections decreases TRM and inc
reases survival after allogeneic bone marrow transplants for leukemia.